ÂÜÀòÂÒÂ×

Bérengère Hennebelle, Pharm.D, has 20 years of experience in the pharmaceutical industry. She began her career in pharmaceutical development services in medium-sized companies (Guerbet, HRA Pharma), combining CMC development and technical-regulatory activities on an international scale. After a university degree in biological therapies, she turned to biotechnological products. She contributed to the CMC strategy and coordinated CMC dossiers of biologics in the FDA and EMA registration phase for a recombinant protein at LFB and then for a gene therapy product at Gensight Biologics. She joined Acticor in 2022 to take over CMC regulatory activities.